Agios Pharmaceuticals, Inc. (FRA:8AP)
22.80
-0.80 (-3.39%)
At close: Jan 30, 2026
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of €1.35 billion as of January 30, 2026. Its market cap has decreased by -26.99% in one year.
Market Cap
1.35B
Enterprise Value
326.11M
Revenue
38.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
€22.80
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from 712.40M to 1.35B, an increase of 89.06%. That is a compound annual growth rate of 5.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.35B | -0.38% |
| Dec 31, 2025 | 1.35B | -25.31% |
| Dec 31, 2024 | 1.81B | 60.74% |
| Dec 29, 2023 | 1.13B | -22.00% |
| Dec 30, 2022 | 1.44B | -8.03% |
| Dec 31, 2021 | 1.57B | -36.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.48B |
| Mainova AG | 2.45B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.80B |
| tonies SE | 1.19B |
| Sedlmayr Grund und Immobilien AG | 932.55M |
| Berliner Effektengesellschaft AG | 879.96M |
| Northern Data AG | 842.90M |